Exun Biocell Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.83%
- Profit Growth 5.20%
- Ebitda 2.93%
- Net Worth 13.91%
- Total Assets 8.56%
About Exun Biocell
Exun Biocell Private Limited (EBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 July 2011 and has a history of 13 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Kumar and Rakhi Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2011PTC222230
- Company No.
222230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Exun Biocell Private Limited offer?
Exun Biocell Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Water Treatment Chemicals.
Who are the key members and board of directors at Exun Biocell?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kumar  | Director | 13-Jul-2011 | Current |
| Rakhi Gupta | Director | 13-Jul-2011 | Current |
Financial Performance of Exun Biocell.
Exun Biocell Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.83% increase. The company also saw a slight improvement in profitability, with a 5.2% increase in profit. The company's net worth Soared by an impressive increase of 13.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exun Biocell?
Unlock access to Exun Biocell's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exun Biocell?
Unlock and access historical data on people associated with Exun Biocell, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exun Biocell, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exun Biocell's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.